Evidence map›Paper›PMID 23348064›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2013

Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis.

Fei Yu, Peng Zhong, Xiaojie Liu, Dalong Sun, Hai-Qing Gao, Qing-Song Liu

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CaNeuropharmacology · 2023
    Article
  6. Article
  7. Review
  8. A Review of Molecular Imaging of Glutamate Receptors.Molecules (Basel, Switzerland) · 2020
    Review
  9. Article
  10. VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  11. Article
  12. The role of human dopamine transporter in NeuroAIDS.Pharmacology & therapeutics · 2018
    Review
  13. Article
  14. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  15. miR-217-casein kinase-2 cross talk regulates ERK activation in ganglioglioma.Journal of molecular medicine (Berlin, Germany) · 2017
    Article
  16. PDE4 Inhibition Restores the Balance Between Excitation and Inhibition in VTA Dopamine Neurons Disrupted by Repeated In Vivo Cocaine Exposure.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fei YuDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Peng Zhong
Xiaojie Liu
Dalong Sun
Hai-Qing Gao
Qing-Song Liu
Medical College of Wisconsin · USShandong University · CN

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR031973 · NCRR · MEDICAL COLLEGE OF WISCONSIN · PI SHAKER, REZA NONE · 2010 to 2011
$7.9M
Synaptic Plasticity in the Ventral Tegmental Area and Cocaine AddictionR01DA024741 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI LIU, QING-SONG · 2008 to 2012
$1.3M
Mechanistic studies of 2-AG inactivation inhibitors as antidepressantsR21MH095921 · NIMH · MEDICAL COLLEGE OF WISCONSIN · PI LIU, QING-SONG · 2012 to 2013
$413k
NCRR NIH HHS UL1 RR031973NCRR NIH HHS UL1RR031973NIDA NIH HHS DA024741NIDA NIH HHS R01 DA024741NIMH NIH HHS MH095921NIMH NIH HHS R21 MH095921
6 · The paper itself

Abstract

Antagonism of group I metabotropic glutamate receptors (mGluR1 and mGluR5) reduces behavioral effects of drugs of abuse, including cocaine. However, the underlying mechanisms remain poorly understood. Activation of mGluR5 increases protein synthesis at synapses. Although mGluR5-induced excessive protein synthesis has been implicated in the pathology of fragile X syndrome, it remains unknown whether group I mGluR-mediated protein synthesis is involved in any behavioral effects of drugs of abuse. We report that group I mGluR agonist DHPG induced more pronounced initial depression of inhibitory postsynaptic currents (IPSCs) followed by modest long-term depression (I-LTD) in dopamine neurons of rat ventral tegmental area (VTA) through the activation of mGluR1. The early component of DHPG-induced depression of IPSCs was mediated by the cannabinoid CB1 receptors, while DHPG-induced I-LTD was dependent on protein synthesis. Western blotting analysis indicates that mGluR1 was coupled to extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin (mTOR) signaling pathways to increase translation. We also show that cocaine conditioning activated translation machinery in the VTA via an mGluR1-dependent mechanism. Furthermore, intra-VTA microinjections of mGluR1 antagonist JNJ16259685 and protein synthesis inhibitor cycloheximide significantly attenuated or blocked the acquisition of cocaine-induced conditioned place preference (CPP) and activation of translation elongation factors. Taken together, these results suggest that mGluR1 antagonism inhibits de novo protein synthesis; this effect may block the formation of cocaine-cue associations and thus provide a mechanism for the reduction in CPP to cocaine.

Indexed as

AnimalsCocaineConditioning, PsychologicalCycloheximideDopaminergic NeuronsDrug InteractionsExtracellular Signal-Regulated MAP KinasesGlycineInhibitory Postsynaptic PotentialsLong-Term Synaptic DepressionMaleMicroinjectionsNerve Tissue ProteinsPeptide Chain Elongation, TranslationalProtein Synthesis InhibitorsQuinolines(3,4-dihydro-2H-pyrano(2,3)b-quinolin-7-yl)-(cis-4-methoxycyclohexyl) methanone3,5-dihydroxyphenylglycineCocaineCycloheximideExtracellular Signal-Regulated MAP KinasesGlycinemetabotropic glutamate receptor type 1mTOR protein, ratNerve Tissue ProteinsProtein Synthesis InhibitorsQuinolinesReceptor, Cannabinoid, CB1Receptors, Metabotropic GlutamateResorcinolsTOR Serine-Threonine Kinases

Identifiers

PMID23348064
PMCPMC3656374
OpenAlexW2048802677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.